| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYCN | Cyclerion Therapeutics, Inc. | MCGUIRE TERRANCE | Director | Aug 09, 2023 | Sale | $3.39 | 8 | 27 | 0 | Aug 11, 2023, 04:25 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Hecht Peter M | Chief Executive Officer | May 19, 2023 | Option Exercise | $8.68 | 225,000 | 1,953,000 | 327,385 | May 22, 2023, 08:43 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | MCGUIRE TERRANCE | Director | Jun 03, 2021 | Buy | $3.12 | 3,322 | 10,365 | 24,957 | Jun 07, 2021, 05:36 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | MCGUIRE TERRANCE | Director | Jun 03, 2021 | Buy | $3.12 | 92,831 | 289,633 | 697,313 | Jun 07, 2021, 05:36 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Hecht Peter M | Chief Executive Officer | Jun 03, 2021 | Buy | $3.28 | 823,170 | 2,699,998 | 2,047,698 | Jun 07, 2021, 05:25 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Hecht Peter M | Chief Executive Officer | May 06, 2021 | Buy | $2.43 | 302,000 | 733,860 | 1,224,528 | May 10, 2021, 08:45 AM | |
| CYCN | Cyclerion Therapeutics, Inc. | Hecht Peter M | Chief Executive Officer | May 04, 2021 | Buy | $2.29 | 300,000 | 687,000 | 524,527 | May 06, 2021, 09:27 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Hecht Peter M | Chief Executive Officer | May 05, 2021 | Buy | $2.53 | 398,001 | 1,006,943 | 922,528 | May 06, 2021, 09:27 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Gjino Anjeza | Chief Financial Officer | Feb 25, 2021 | Sale | $4.00 | 1,824 | 7,296 | 31,599 | Mar 01, 2021, 04:23 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Wright Christopher I | Chief Medical Officer | Feb 25, 2021 | Sale | $3.99 | 2,637 | 10,522 | 42,728 | Mar 01, 2021, 12:00 AM | |
| CYCN | Cyclerion Therapeutics, Inc. | Currie Mark G | President and CSO | Dec 28, 2020 | Sale | $3.01 | 20,107 | 60,522 | 251,648 | Dec 30, 2020, 01:14 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Busch Andreas | Chief Innovation Officer | Nov 09, 2020 | Buy | $2.53 | 125,000 | 316,250 | 254,704 | Nov 12, 2020, 05:05 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Huyett William | Chief Financial Officer | Nov 06, 2020 | Sale | $2.52 | 3,827 | 9,644 | 67,590 | Nov 10, 2020, 07:07 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Huyett William | Chief Financial Officer | Feb 21, 2020 | Sale | $5.12 | 3,559 | 18,222 | 71,417 | Feb 25, 2020, 04:11 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Currie Mark G | President | Dec 27, 2019 | Sale | $2.55 | 25,000 | 63,750 | 296,755 | Dec 31, 2019, 05:55 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Currie Mark G | President | Dec 30, 2019 | Sale | $2.48 | 25,000 | 62,000 | 271,755 | Dec 31, 2019, 05:55 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Busch Andreas | Chief Innovation Officer | Nov 15, 2019 | Buy | $1.82 | 125,000 | 227,500 | 125,000 | Nov 19, 2019, 04:02 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Huyett William | Chief Financial Officer | Nov 08, 2019 | Sale | $2.05 | 3,922 | 8,040 | 74,976 | Nov 12, 2019, 04:26 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Hecht Peter M | Chief Executive Officer | Jul 10, 2019 | Option Exercise | $6.04 | 2,000 | 12,080 | 225,192 | Jul 12, 2019, 04:09 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | MCGUIRE TERRANCE | Director | Apr 08, 2019 | Buy | $16.00 | 21,635 | 346,160 | 21,635 | Apr 10, 2019, 04:14 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | MCGUIRE TERRANCE | Director | Apr 08, 2019 | Buy | $16.00 | 604,482 | 9,671,712 | 604,482 | Apr 10, 2019, 04:14 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | SCHULMAN AMY W | Director | Apr 08, 2019 | Buy | $16.00 | 604,482 | 9,671,712 | 604,482 | Apr 10, 2019, 04:13 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | SCHULMAN AMY W | Director | Apr 08, 2019 | Buy | $16.00 | 21,635 | 346,160 | 21,635 | Apr 10, 2019, 04:13 PM | |
| CYCN | Cyclerion Therapeutics, Inc. | Currie Mark G | President | Apr 02, 2019 | Buy | $14.81 | 270,107 | 4,000,285 | 321,755 | Apr 03, 2019, 07:42 PM |
Menu